4-[(tert-butylamino)methyl]-3-ethoxycarbonyl-5-(4-methoxyphenyl)-1-phenyl-1H-pyrazole chloride

ID: ALA4764697

PubChem CID: 162661694

Max Phase: Preclinical

Molecular Formula: C24H30ClN3O3

Molecular Weight: 407.51

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCOC(=O)c1nn(-c2ccccc2)c(-c2ccc(OC)cc2)c1CNC(C)(C)C.Cl

Standard InChI:  InChI=1S/C24H29N3O3.ClH/c1-6-30-23(28)21-20(16-25-24(2,3)4)22(17-12-14-19(29-5)15-13-17)27(26-21)18-10-8-7-9-11-18;/h7-15,25H,6,16H2,1-5H3;1H

Standard InChI Key:  AIEPXPZEZATLGH-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 31 32  0  0  0  0  0  0  0  0999 V2000
    5.1249  -10.8997    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.2458  -10.6956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4624  -11.4956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0469  -10.9079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9651  -15.2371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9640  -16.0645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6787  -16.4773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3952  -16.0640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3924  -15.2335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6769  -14.8244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6787  -14.0036    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3456  -13.5175    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0883  -12.7328    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2621  -12.7366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0118  -13.5237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2322  -13.7848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6161  -13.2343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8336  -13.4929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6658  -14.3016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2868  -14.8511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0670  -14.5896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5707  -12.0636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3915  -12.1468    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.8740  -11.4776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6947  -11.5609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2324  -11.3112    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7736  -12.0718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9536  -12.1625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6451  -11.5883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8829  -14.5617    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2662  -14.0138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  3  2  1  0
  4  3  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
 12 13  2  0
 11 12  1  0
 13 14  1  0
 14 15  2  0
 15 11  1  0
 10 11  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 15 16  1  0
 13 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 22 26  2  0
 14 27  1  0
 27 28  1  0
 28  3  1  0
  3 29  1  0
 19 30  1  0
 30 31  1  0
M  END

Associated Targets(Human)

U-251 (51189 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
786-0 (47912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-3 (48710 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HaCaT (4069 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 407.51Molecular Weight (Monoisotopic): 407.2209AlogP: 4.61#Rotatable Bonds: 7
Polar Surface Area: 65.38Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.48CX LogP: 4.63CX LogD: 3.51
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.58Np Likeness Score: -1.01

References

1. da Silva MJV,Jacomini AP,Figueiredo MC,Back DF,Foglio MA,Ruiz ALTG,Paula FR,Rosa FA.  (2021)  Efficient synthesis and antitumor evaluation of 4-aminomethyl-N-arylpyrazoles: Discovery of potent and selective agents for ovarian cancer.,  29  [PMID:33214037] [10.1016/j.bmc.2020.115835]

Source